James Lappin
Seminars
Thursday 8th October 2026
Rethinking the Pharma-Diagnostic Partnership: How Specialist Oversight Can Reduce Complexity, Manage Risk & Optimize the Clinical Trial Lifecycle
11:00 am
- Simplify complex IVD study responsibilities with clearer ownership and accountability across the clinical trial lifecycle
- Reduce handovers, gaps and duplication across diagnostic partners, vendors and workstreams
- Strengthen oversight and coordination across multiple diagnostic partners and activities
- Reduce risk, save time and ease pressure on internal teams through a more integrated approach
